Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes-Reference-Cited by-同舟云学术

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

Published:2018-03-29 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lucifora Julie,Bonnin Marc,Aillot Ludovic,Fusil Floriane,Maadadi Sarah,Dimier Laura,Michelet Maud,Floriot Océane,Ollivier Anaïs,Rivoire Michel,Ait-Goughoulte Malika,Daffis Stéphane,Fletcher Simon P.,Salvetti Anna,Cosset François-Loïc,Zoulim Fabien,Durantel David

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-23525-w.pdf

Reference33 articles.

1. Zeisel, M. B. et al. Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure. Gut. https://doi.org/10.1136/gutjnl-2014-308943 (2015).

2. Durantel, D. & Zoulim, F. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus. J Hepatol 64, S117–131, https://doi.org/10.1016/j.jhep.2016.02.016 (2016).

3. Pandey, S., Kawai, T. & Akira, S. Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors. Cold Spring Harb Perspect Biol 7, a016246, https://doi.org/10.1101/cshperspect.a016246 (2015).

4. Isorce, N. et al. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus. Antiviral Res 130, 36–45, https://doi.org/10.1016/j.antiviral.2016.03.008 (2016).

5. Konerman, M. A. & Lok, A. S. Interferon Treatment for Hepatitis B. Clin Liver Dis 20, 645–665, https://doi.org/10.1016/j.cld.2016.06.002 (2016).

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu‐like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll‐like receptor 7 agonist ruzotolimod;Clinical and Translational Science;2024-08

2. A novel TLR7 agonist exhibits antiviral activity against pseudorabies virus1;Journal of Integrative Agriculture;2024-07

3. Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review;Frontiers in Immunology;2024-03-13

4. A Synthetic Multivalent Lipopeptide Derived from Pam3CSK4 with Irreversible Influenza Inhibition and Immuno‐Stimulating Effects;Small;2024-03-04

5. Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators;Viruses;2023-11-30